Technical Analysis for OBIO - Orchestra BioMed Holdings, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Fell Below 20 DMA | Bearish | 2.72% | |
| Fell Below 50 DMA | Bearish | 2.72% | |
| 200 DMA Resistance | Bearish | -7.84% | |
| Bearish Engulfing | Bearish | -7.84% | |
| Stochastic Sell Signal | Bearish | -7.84% | |
| Outside Day | Range Expansion | -7.84% | |
| Overbought Stochastic | Strength | -7.84% |
| Alert | Time |
|---|---|
| 20 DMA Resistance | about 22 hours ago |
| Up 5% | about 22 hours ago |
| Up 3% | about 22 hours ago |
| Fell Below Previous Day's Low | about 22 hours ago |
| Down 2 % | about 22 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Orchestra BioMed, Inc. operates as a therapeutic device company that develops therapeutic treatments and products for cardiovascular diseases. It offers BackBeat Cardiac Neuromodulation Therapy (CNT), a patented, intelligent bioelectronic treatment for hypertension; Virtue SAB, a patented drug/device combination product for the treatment of artery disease; FreeHold Retractors, a minimally invasive surgical device solution; and Virtue SEB, a drug-eluting balloon angioplasty system for the treatment of coronary artery disease. Orchestra BioMed, Inc. has a strategic collaboration with Medtronic to develop BackBeat CNT as a potential treatment for hypertension in patients who are indicated for a cardiac pacemaker. The company was incorporated in 2017 and is based in New Hope, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Hypertension Cardiovascular Disease Neuromodulation Artery Disease Angioplasty Coronary Artery Disease Medtronic
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Hypertension Cardiovascular Disease Neuromodulation Artery Disease Angioplasty Coronary Artery Disease Medtronic
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.68 |
| 52 Week Low | 4.22 |
| Average Volume | 56,680 |
| 200-Day Moving Average | 6.16 |
| 50-Day Moving Average | 5.47 |
| 20-Day Moving Average | 5.43 |
| 10-Day Moving Average | 5.68 |
| Average True Range | 0.45 |
| RSI (14) | 46.81 |
| ADX | 21.81 |
| +DI | 20.90 |
| -DI | 17.52 |
| Chandelier Exit (Long, 3 ATRs) | 5.02 |
| Chandelier Exit (Short, 3 ATRs) | 6.10 |
| Upper Bollinger Bands | 6.17 |
| Lower Bollinger Band | 4.70 |
| Percent B (%b) | 0.4 |
| BandWidth | 26.90 |
| MACD Line | 0.07 |
| MACD Signal Line | 0.07 |
| MACD Histogram | -0.0045 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.98 | ||||
| Resistance 3 (R3) | 5.95 | 5.70 | 5.87 | ||
| Resistance 2 (R2) | 5.70 | 5.52 | 5.71 | 5.83 | |
| Resistance 1 (R1) | 5.49 | 5.41 | 5.60 | 5.52 | 5.79 |
| Pivot Point | 5.24 | 5.24 | 5.29 | 5.25 | 5.24 |
| Support 1 (S1) | 5.03 | 5.06 | 5.14 | 5.06 | 4.79 |
| Support 2 (S2) | 4.78 | 4.95 | 4.79 | 4.75 | |
| Support 3 (S3) | 4.57 | 4.78 | 4.72 | ||
| Support 4 (S4) | 4.60 |
